Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$0.46 - $1.3 $2,326 - $6,574
-5,057 Reduced 95.04%
264 $0
Q4 2022

Feb 10, 2023

SELL
$0.29 - $0.57 $4,318 - $8,487
-14,890 Reduced 73.67%
5,321 $2,000
Q3 2022

Nov 14, 2022

SELL
$0.53 - $1.9 $7,636 - $27,375
-14,408 Reduced 41.62%
20,211 $11,000
Q2 2022

Aug 12, 2022

BUY
$1.58 - $7.36 $54,698 - $254,795
34,619 New
34,619 $54,000

About Tonix Pharmaceuticals Holding Corp.


  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.25M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.